CHONDRONEST ^Company

ChondroNest is developing the application of this intellectual property for the reconstruction of Hyaline cartilage. They are aiming to conduct preclinical tests on animal models for two indications, the Osteochondritis and subsequently the Osteoarthrosis. After the first in-man preclinical trials the product will be licensed to major MedTech companies for sales and marketing while they will retain the production of ChondroNest™ pastes.